DD299429A5 - Neue 1-oxa-2-oxo-8-aza-spiro[4,5]dekan-derivate und verfahren zur herstellung dieser verbindungen - Google Patents

Neue 1-oxa-2-oxo-8-aza-spiro[4,5]dekan-derivate und verfahren zur herstellung dieser verbindungen Download PDF

Info

Publication number
DD299429A5
DD299429A5 DD90343361A DD34336190A DD299429A5 DD 299429 A5 DD299429 A5 DD 299429A5 DD 90343361 A DD90343361 A DD 90343361A DD 34336190 A DD34336190 A DD 34336190A DD 299429 A5 DD299429 A5 DD 299429A5
Authority
DD
German Democratic Republic
Prior art keywords
general formula
group
oxo
oxa
above meaning
Prior art date
Application number
DD90343361A
Other languages
German (de)
English (en)
Inventor
Aniko Gere
Katalin Csomor
Mihaly Bodo
Judit Laszy
Zsolt Szentirmay
Edit Toth
Jozsef Toerley
Laszlo Szporny
Bela Kiss
Egon Karpati
Eva Palosi
Dora Groo
Istvan Laszlovszky
Zsolt Szombathelyi
Adam Sarkadi
Original Assignee
�������@������@����������@����@��Kk��
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by �������@������@����������@����@��Kk�� filed Critical �������@������@����������@����@��Kk��
Publication of DD299429A5 publication Critical patent/DD299429A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/10—Spiro-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Hospice & Palliative Care (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Hydrogenated Pyridines (AREA)
DD90343361A 1989-08-10 1990-08-09 Neue 1-oxa-2-oxo-8-aza-spiro[4,5]dekan-derivate und verfahren zur herstellung dieser verbindungen DD299429A5 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU894095A HU204530B (en) 1989-08-10 1989-08-10 Process for producing new 1-oxa-2-oxo-8-aza-spiro(4,5)decane derivatives and pharmaceutical compositions containing them
SG96294A SG96294G (en) 1989-08-10 1994-07-16 1-oxa-2-oxo-8-azaspiro[4,5] decane derivatives, processes for their preparation and pharmaceutical compositions thereof

Publications (1)

Publication Number Publication Date
DD299429A5 true DD299429A5 (de) 1992-04-16

Family

ID=26317733

Family Applications (1)

Application Number Title Priority Date Filing Date
DD90343361A DD299429A5 (de) 1989-08-10 1990-08-09 Neue 1-oxa-2-oxo-8-aza-spiro[4,5]dekan-derivate und verfahren zur herstellung dieser verbindungen

Country Status (23)

Country Link
US (1) US5118687A (bg)
EP (1) EP0414421B1 (bg)
JP (1) JPH0749431B2 (bg)
KR (1) KR940006635B1 (bg)
AT (1) ATE103920T1 (bg)
AU (1) AU622039B2 (bg)
BG (1) BG60436B2 (bg)
DD (1) DD299429A5 (bg)
DE (1) DE69007904T2 (bg)
DK (1) DK0414421T3 (bg)
ES (1) ES2052180T3 (bg)
FI (1) FI93455C (bg)
HK (1) HK145994A (bg)
HR (1) HRP920778A2 (bg)
HU (2) HU204530B (bg)
IE (1) IE64911B1 (bg)
IL (1) IL95320A (bg)
NO (1) NO177962C (bg)
NZ (1) NZ234848A (bg)
PL (3) PL163593B1 (bg)
SG (1) SG96294G (bg)
SI (1) SI9011538A (bg)
ZA (1) ZA906302B (bg)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
YU150489A (sh) * 1989-08-10 1992-12-21 W.L. Gore & Co. Gmbh. Uređaj za ispitivanje odevnih predmeta na nepromočivost
WO2001028602A1 (en) * 1999-10-15 2001-04-26 Genetics Institute, Inc. Formulations of hyaluronic acid for delivery of osteogenic proteins
KR20020091462A (ko) * 2001-05-30 2002-12-06 삼성광주전자 주식회사 원료 굳음 방지기능을 갖는 자동판매기 및 그 제어방법
GB201416346D0 (en) * 2014-09-16 2014-10-29 Shire Internat Gmbh Spirocyclic derivatives

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR96352E (fr) * 1967-12-29 1972-06-16 Science Union & Cie Nouveaux dérives du spiro (4,5) decane et leur procédé de préparation.
BE790675A (fr) * 1971-10-29 1973-04-27 Science Union & Cie Nouveaux derives de l'oxa-1 diaza-3,8 spiro (4,5) decane
EP0189370A3 (de) * 1985-01-16 1988-01-27 Sandoz Ag Spiro-dioxolane, -dithiolane und -oxothiolane
HU204529B (en) * 1989-08-10 1992-01-28 Richter Gedeon Vegyeszet Process for producing new 1-oxa-2-oxo-8-aza-spiro(4,5)decane derivatives and pharmaceutical compositions containing them
KR940003491B1 (ko) * 1989-08-10 1994-04-23 리히터 게데온 베기에스제티 기아르 알.티 4,4-이중 치환된 피페리딘 유도체와 그 제조방법 및 상기 화합물을 함유하는 약제학적 조성물

Also Published As

Publication number Publication date
EP0414421B1 (en) 1994-04-06
HRP920778A2 (en) 1998-02-28
EP0414421A3 (en) 1991-07-24
IL95320A (en) 1994-01-25
KR910004632A (ko) 1991-03-29
KR940006635B1 (ko) 1994-07-23
HUT55786A (en) 1991-06-28
NO903512L (no) 1991-02-11
NO177962B (no) 1995-09-18
DE69007904D1 (de) 1994-05-11
EP0414421A2 (en) 1991-02-27
NZ234848A (en) 1992-03-26
ATE103920T1 (de) 1994-04-15
PL163370B1 (pl) 1994-03-31
PL291701A1 (en) 1992-05-04
US5118687A (en) 1992-06-02
BG60436B2 (bg) 1995-03-31
IE902884A1 (en) 1991-02-27
DK0414421T3 (da) 1994-05-16
HU210072A9 (en) 1995-02-28
ES2052180T3 (es) 1994-07-01
AU6080790A (en) 1991-02-14
SG96294G (en) 1994-10-28
ZA906302B (en) 1991-06-26
IL95320A0 (en) 1991-06-30
DE69007904T2 (de) 1994-07-21
PL286440A1 (en) 1992-01-27
AU622039B2 (en) 1992-03-26
HK145994A (en) 1994-12-30
JPH0749431B2 (ja) 1995-05-31
PL163431B1 (pl) 1994-03-31
HU204530B (en) 1992-01-28
SI9011538A (sl) 1998-08-31
NO903512D0 (no) 1990-08-09
FI93455B (fi) 1994-12-30
PL291702A1 (en) 1992-05-04
PL163593B1 (en) 1994-04-29
FI903972A0 (fi) 1990-08-10
FI93455C (fi) 1995-04-10
IE64911B1 (en) 1995-09-20
JPH0377884A (ja) 1991-04-03
NO177962C (no) 1995-12-27

Similar Documents

Publication Publication Date Title
DE60030574T2 (de) Fünfgliedrige derivate von heterozyklen und ihre verwendung als monoaminoxidase-inhibitoren
DE602005006101T2 (de) Substituierte chinoline und deren verwendung als inhibitoren von mycobakterien
EP0528922B1 (de) Neue sulfonylverbindungen
EP0204349A2 (de) Neue heteroaromatische Aminderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
DE69434888T2 (de) 5-ht4-rezeptor-antagonisten
DE2411382B2 (de) 2-Tetrahydrofurfuryl-6,7-benzomorphane, Verfahren zur Herstellung und deren Verwendung
EP0768302A2 (de) Hydroxypyridinone
DD299428A5 (de) Neue 2-oxo-4-methylen-8-aza-spiro[4,5]dekan-derivate und verfahren zu ihrer herstellung
DE60307875T2 (de) Imidazopyrin-derivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusamensetzungen
DE3342164A1 (de) Antipsychotisch wirkende benzoxazine, verfahren zu deren herstellung sowie pharmazeutische zubereitungen, die diese enthalten
DE69533194T2 (de) PYRAZOLO(3,4-g)CHINOXALINE ALS PDGF-REZEPTOR PROTEIN TYROSIN-KINASE INHIBITOREN
DE69815700T2 (de) Tetrahydro gamma-carboline
DD149071A5 (de) Herstellung 2-substituierter trans-5-aryl-2,3,4,4a,5,9b-hexahydro-1h-pyrido eckige klammer auf 4,3-b eckige klammer zu indole
DE60214138T2 (de) Isoxazolin-derivate als antidepressiva
DE3309596A1 (de) 2-substituierte 1-(3'-aminoalkyl)-1,2,3,4-tetrahydro-ss-carboline, ihre herstellung und verwendung als arzneimittel
DE1670772A1 (de) Verfahren zur Herstellung von Benzoxazin-Derivaten
DD299427A5 (de) Neue 1-oxa-2-oxo-8-aza-spiro(4,5)dekan-derivate und verfahren zu ihrer herstellung
DD235256A5 (de) Verfahren zur herstellung neuer substituierter pyrrolidinone
EP1252163B1 (de) 4-pyridyl- und 2,4-pyrimidinyl-substituierte pyrrolderivate und ihre anwendung in der pharmazie
DD299425A5 (de) Neue 4,4-disubstituierte piperidin-derivate und verfahren zu ihrer herstellung
DD299429A5 (de) Neue 1-oxa-2-oxo-8-aza-spiro[4,5]dekan-derivate und verfahren zur herstellung dieser verbindungen
EP0298921B1 (de) 1,2-Benzisoxazole und 1,2-Benzisothiazole
EP0332064A2 (de) Neue Benzocycloheptenderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu deren Herstellung
DD210270A5 (de) Verfahren zur herstellung substituierter hexahydropyrrolo (1,2-a)-chinolin-, hexahydro-1h-pyrido (1,2-a) chinolin-, hexahydrobenzo(e)inden- und octahydrophenanthrenzns-mittel
DE602004002990T2 (de) Derivate von Benzothiazin und Benzothiadiazin, Verfahren zu ihrer Herstellung und pharmazeutische Zubereitungen diese enthaltend

Legal Events

Date Code Title Description
ENJ Ceased due to non-payment of renewal fee